{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:01:32Z","timestamp":1792177292052,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Psychiatry"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1097\/01.jgp.0000200589.01396.6d","type":"journal-article","created":{"date-parts":[[2006,2,27]],"date-time":"2006-02-27T13:19:03Z","timestamp":1141046343000},"page":"191-210","source":"Crossref","is-referenced-by-count":691,"title":["Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-analysis of Randomized, Placebo-Controlled Trials"],"prefix":"10.1016","volume":"14","author":[{"given":"Lon S.","family":"Schneider","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dagerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Insel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib1","first-page":"1","article-title":"The Expert Consensus Guideline Series: treatment of agitation in older persons with dementia","author":"Alexopoulos","year":"1998","journal-title":"Postgrad Med"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib2","first-page":"1","article-title":"The Expert Consensus Guideline Series: treatment of dementia and its behavioral disturbances","author":"Alexopoulos","year":"2005","journal-title":"Postgrad Med"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial","volume":"60","author":"Katz","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib4","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib5","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","article-title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial","volume":"57","author":"Street","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","volume":"64","author":"Brodaty","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib7","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gps.1032","article-title":"Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease","volume":"19","author":"De Deyn","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib8","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib9","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1097\/00019442-200508000-00012","article-title":"Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia","volume":"13","author":"Deberdt","year":"2005","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib10","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1001\/jama.293.5.596","article-title":"Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence","volume":"293","author":"Sink","year":"2005","journal-title":"JAMA"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/gps.504","article-title":"A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients","volume":"16","author":"Chan","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"issue":"suppl 1","key":"10.1097\/01.JGP.0000200589.01396.6d_bib12","first-page":"93","article-title":"Quetiapine in nursing home residents with Alzheimer's dementia and psychosis. Poster presented at the 15th Annual Meeting of the American Association for Geriatric Psychiatry; Feb 24\u201327; Orlando, Fla","volume":"10","author":"Tariot","year":"2002","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib13","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"Schneider","year":"2005","journal-title":"JAMA"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib15","series-title":"The Cochrane Library, Issue 1, 2005","year":"2005"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00019442-200002000-00004","article-title":"Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome","volume":"8","author":"Jeste","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib17","unstructured":"Racoosin JA: Evaluating a safety signal in the postmarking period: cerebrovascular adverse events associated with risperidone and olanzapine. Paper presented at the 17th Annual Meeting of the American Association for Geriatric Psychiatry; Feb 21\u201324, 2004; Baltimore"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib18","unstructured":"Bristol-Myers Squibb Medical Letter. Labeling Change for Abilify on Risk of CVA in Elderly. Feb 10, 2005"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib19","unstructured":"Schneider LS, Tariot PN, Mintzer J, et al: Cerebrovascular adverse events and quetiapine: a pooled analysis in elderly patients with dementia. Paper presented at the 18th Annual Meeting of the American Association for Geriatric Psychiatry; March 3\u20136, 2005; San Diego"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib20","series-title":"Review Manager (RevMan) [computer program]. Version 4.2","year":"2004"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib21","unstructured":"Howanitz E, Wisotzek I: Olanzapine versus placebo in the treatment of behavioral disturbances associated with vascular dementia. Poster presented at the 14th Annual Meeting of the American Association for Geriatric Psychiatry; Feb 23\u201326, 2001; San Francisco"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib22","first-page":"534","article-title":"A clinical update on olanzapine treatment in schizophrenia and in elderly Alzheimer's disease patients","volume":"31","author":"Satterlee","year":"1995","journal-title":"Psychopharmacol Bull"},{"issue":"suppl","key":"10.1097\/01.JGP.0000200589.01396.6d_bib23","first-page":"9","article-title":"Behavioral symptoms in Alzheimer's disease: phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib24","doi-asserted-by":"crossref","first-page":"M77","DOI":"10.1093\/geronj\/44.3.M77","article-title":"A description of agitation in a nursing home","volume":"44","author":"Cohen-Mansfield","year":"1989","journal-title":"J Gerontol"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/geronj\/39.2.187","article-title":"The Brief Psychiatric Rating Scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit","volume":"39","author":"Overall","year":"1984","journal-title":"J Gerontol"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib26","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib27","first-page":"218","article-title":"Clinical Global Impressions (CGI)","author":"Guy","year":"1976","journal-title":"In ECDEU Assessment Manual for Psychopharmacology"},{"issue":"suppl 2","key":"10.1097\/01.JGP.0000200589.01396.6d_bib28","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's Disease Cooperative Study\u2013Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib29","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-3223(88)90038-8","article-title":"Cornell Scale for Depression in Dementia","volume":"23","author":"Alexopoulos","year":"1988","journal-title":"Biol Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00019442-200409000-00008","article-title":"Risperidone and falls in ambulatory nursing home residents with dementia and psychosis or agitation: secondary analysis of a double-blind, placebo-controlled trial","volume":"12","author":"Katz","year":"2004","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib31","unstructured":"Breder C, Swanink R, Marcus R, et al: Dose-ranging study of aripiprazole in patients with Alzheimer's dementia. Poster presented at the 9th International Conference on Alzheimer's Disease and Related Disorders; July 17\u201322, 2004; Philadelphia"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib32","doi-asserted-by":"crossref","unstructured":"Streim J, Breder C, Swanink R, et al: Flexible dose aripiprazole in psychosis of Alzheimer's dementia (AD). Poster presented at the 157th American Psychiatric Association Annual Meeting; May 1\u20136, 2004; New York","DOI":"10.1016\/S0197-4580(04)80643-2"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib33","unstructured":"Kujawa M, Marcus R, Breder C, et al: Safety profile of aripiprazole in psychosis of Alzheimer's dementia: pooled analysis. Poster presented at the 9th International Conference on Alzheimer's Disease and Related Disorders; July 17\u201322, 2004; Philadelphia"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib34","unstructured":"Stock E, Breder C, Goyvaerts H, et al: Safety profile of aripiprazole in psychosis of Alzheimer's dementia: pooled analysis. Poster presented at the American Psychiatric Association Annual Meeting; May 1\u20136, 2004; New York"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib35","unstructured":"De Deyn PP, Jeste DV, Mintzer JE, et al: Aripiprazole in dementia of the Alzheimer's type. Poster presented at the 16th Annual Meeting American Association for Geriatric Psychiatry; March 1\u20134, 2003; Honolulu"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3928\/0048-5713-20000301-12","article-title":"Olanzapine for psychotic conditions in the elderly","volume":"30","author":"Street","year":"2000","journal-title":"Psychiatric Annals"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib37","series-title":"Olanzapine (Zyprexa): A Novel Antipsychotic","first-page":"416","article-title":"Olanzapine in dementia","author":"Street","year":"2000"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib38","unstructured":"Cavazzoni P, Young CA, Polzer J, et al: Incidence of cerebrovascular adverse events and mortality during antipsychotic clinical trials of elderly patients with dementia. Poster presented at the 44th Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting (modifications added); June 1\u20134, 2004; Phoenix"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib39","unstructured":"Deberdt W, Dysken MW, Rappaport SA, et al: Placebo-controlled comparison of olanzapine and risperidone in the treatment of psychosis and behavioral disturbances in patients with dementia. Poster presented at the American Geriatrics Society; May 17\u201321, 2004; Las Vegas"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib40","unstructured":"Kennedy JS, Young CA, Hoffman VP, et al: A placebo-controlled 10-week prospective comparison of the occurrence of falls in dementia: olanzapine versus risperidone. Poster presented at the International College of Geriatric Psychoneuropharmacology; Oct 10\u201312, 2002; Barcelona, Spain"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib41","unstructured":"Kennedy JS, Deberdt W, Micca J, et al: The effect of olanzapine on cognition in patients with Alzheimer's disease without psychosis or agitation. Poster presented at the International College of Geriatric Psychoneuropharmacology; Oct 14\u201316, 2004; Basel, Switzerland"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib42","unstructured":"Zhong K, Tariot P, Minkwitz M, et al: Quetiapine for the treatment of agitation in elderly institutionalized patients with dementia: a randomized, double-blind trial. Poster presented at the 9th International Conference on Alzheimer's Disease and Related Disorders; July 17\u201322, 2004; Philadelphia"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib43","unstructured":"De Deyn PP, DeSmedt G: Risperidone in the treatment of behavioral disturbances in elderly patients with dementia. Poster presented at the Eighth Congress of the International Psychogeriatric Association; Aug 17\u201322, 1997; Jerusalem"},{"key":"10.1097\/01.JGP.0000200589.01396.6d_bib44","unstructured":"Mintzer J, Weiner M, Greenspan A, et al: Efficacy and safety of a flexible dose of risperidone versus placebo in the treatment of psychosis of Alzheimer's disease. Poster presented at the International College of Geriatric Psychopharmacology; Oct 14\u201317, 2004; Basel, Switzerland"}],"container-title":["The American Journal of Geriatric Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112620351?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1064748112620351?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T23:26:13Z","timestamp":1555457173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1064748112620351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1064748112620351"],"URL":"https:\/\/doi.org\/10.1097\/01.jgp.0000200589.01396.6d","relation":{},"ISSN":["1064-7481"],"issn-type":[{"value":"1064-7481","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}